Voyager Therapeutics
Utility Patent Applications
Last updated:
List of all Voyager Therapeutics patents 49 in total
| Status | Patent |
|---|---|
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE Filling date: 6 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS Filling date: 6 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) Filling date: 6 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV) Filling date: 6 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: CLOSED-ENDED LINEAR DUPLEX DNA FOR NON-VIRAL GENE TRANSFER Filling date: 6 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND DISORDERS ASSOCIATED WITH THE SPINAL CORD Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: MODULATORY POLYNUCLEOTIDES Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: MODULATORY POLYNUCLEOTIDES Filling date: 6 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: COMPOSITIONS FOR THE TREATMENT OF DISEASE Filling date: 6 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: METHODS AND SYSTEMS FOR PRODUCING AAV PARTICLES Filling date: 6 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: REDIRECTION OF TROPISM OF AAV CAPSIDS Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: EXPRESSION VECTORS FOR LARGE-SCALE PRODUCTION OF rAAV IN THE BACULOVIRUS/Sf9 SYSTEM Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: FRATAXIN EXPRESSION CONSTRUCTS HAVING ENGINEERED PROMOTERS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: REDIRECTION OF TROPISM OF AAV CAPSIDS Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR DELIVERY OF AAV Filling date: 6 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: CANNULA SYSTEM AND USE THEREOF Filling date: 6 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: CLOSED-ENDED LINEAR DUPLEX DNA FOR NON-VIRAL GENE TRANSFER Filling date: 6 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: SYSTEMS AND METHODS FOR PRODUCING GENE THERAPY FORMULATIONS Filling date: 6 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: METHODS FOR MEASURING THE TITER AND POTENCY OF VIRAL VECTOR PARTICLES Filling date: 6 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: ENGINEERED NUCLEIC ACID CONSTRUCTS ENCODING AAV PRODUCTION PROTEINS Filling date: 6 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE Filling date: 6 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: ENGINEERED UNTRANSLATED REGIONS (UTR) FOR AAV PRODUCTION Filling date: 6 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: ASSAYS FOR THE DETECTION OF AAV NEUTRALIZING ANTIBODIES Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: AAV VARIANTS WITH ENHANCED TROPISM Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND DISORDERS ASSOCIATED WITH THE SPINAL CORD Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: METHODS FOR MEASURING THE POTENCY OF AADC VIRAL VECTORS Filling date: 6 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR DELIVERY OF AAV Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: DIRECTED EVOLUTION Filling date: 6 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: AAV SEROTYPES FOR BRAIN SPECIFIC PAYLOAD DELIVERY Filling date: 6 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE Filling date: 6 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR DELIVERY OF AAV Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) Filling date: 6 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: INSECT CELL MANUFACTURED PARTIAL SELF-COMPLEMENTARY AAV GENOMES Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: COMPOSITIONS AND METHODS OF TREATING HUNTINGTON'S DISEASE Filling date: 6 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: MODULATORY POLYNUCLEOTIDES Filling date: 6 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: RESCUE OF CENTRAL AND PERIPHERAL NEUROLOGICAL PHENOTYPE OF FRIEDREICH'S ATAXIA BY INTRAVENOUS DELIVERY Filling date: 6 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) Filling date: 6 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) Filling date: 6 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: TRAJECTORY ARRAY GUIDE SYSTEM Filling date: 6 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: MODULATORY POLYNUCLEOTIDES Filling date: 6 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: COMPOSITIONS FOR THE TREATMENT OF DISEASE Filling date: 6 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) Filling date: 6 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: COMPOSITIONS AND METHODS OF TREATING HUNTINGTON'S DISEASE Filling date: 6 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: MODULATORY POLYNUCLEOTIDES Filling date: 6 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: CHIMERIC CAPSIDS Filling date: 6 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES Filling date: 6 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE Filling date: 6 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE Filling date: 6 Sep 2025 Issue date: 14 Nov 2019 |
Showing 1 to 49 of 49 patents.